ArticleInnovation in aging2025
Toward a payment model for augmenting Adult Day Services (ADS) with caregiver support: costs, willingness, and ability to pay for the ADS Plus program.
Article in Innovation in aging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objectives: The evidence-based Adult Day Services (ADS) Plus program, delivered by ADS staff to caregivers, offers dementia education, support, and strategies to manage care challenges and has been shown in randomized trials to decrease caregiver depressive symptoms and increase ADS utilization. This study examines costs, cost savings, and caregiver willingness to pay (WTP) and ability to pay (ATP) for this evidence-based program. Research Design and Methods: In a 34-site cluster-randomized trial (16 ADS Plus sites; 18 ADS-only usual care sites) involving 203 caregivers, we surveyed program delivery costs, payer-perspective costs (healthcare utilization, formal care/social services utilization), and societal-perspective costs (caregiver time + payer costs) at baseline and 12-months. Enrollees were caregivers who reported on their outcomes and those of the person living with dementia. Costs were calculated using unit costs or appropriate wage rates. We assessed mean per-dyad costs and the between-group difference in mean change in payer and societal costs from baseline to 12-months. Multilevel mixed models considered clustering, and caregivers' WTP and ATP were evaluated. Results: ADS Plus delivery costs were $433/dyad over 12-months. From the payer perspective, ADS Plus resulted in nonstatistically significant but policy-significant cost savings of $1,501 (95% CI: -$2,771 to $4,804). From a societal perspective, ADS Plus led to cost savings of $1,185 (95% CI: -$11,187 to $7,036). ADS Plus caregivers' median per-session WTP was $90 at baseline and $100 at 12-months, compared to $50 and $100 for usual care. ADS Plus caregivers' median ATP was $31.50 at baseline and $50 at 12-months, versus $25 at both timepoints for usual care. Discussion and Implications: Adult Day Services Plus yielded meaningful cost savings, though statistical significance was not achieved. Caregivers were WTP and ATP toward ADS Plus sessions, which could offset program costs. This study elucidates the financial implications of incorporating caregiver support into community-based dementia care programs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.